Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Adaptive mutations of SARS-CoV-2 are rare and unlikely to be transmitted, but when they are transmitted they can have a big impact, finds a new study.

coronavirus

The study, led by Dr Katrina Lythgoe (Big Data Institute) and published today in Scienceused deep sequencing to obtain multiple SARS-CoV-2 genomic sequences per individual to characterise the genetic variation of their viral population.

The results indicate that acute SARS-CoV-2 infections tend to have few, if any, genetic variants. Even when mutations do arise, it will be hard for them to spread as most of the time only the most common variant will be passed on and the others will be lost. In rarer cases, a minority variant might get through and become the consensus sequence, or there might be co-transmission of multiple variants, leading to a mixed infection. This underlines the need to drive down the number of infections, making these rare events even rarer, and continued monitoring of SARS-CoV-2, so we can detect concerning new variants and act before they become dominant in a population.

Read more in a blog on the Fraser Group website.

Similar stories

Study reveals ‘stop-eating’ response to DNA damage

A new study from the MRC Weatherall Institute of Molecular Medicine sheds light on the mechanism by which DNA damage suppresses appetite, a finding with implications for understanding the appetite lowering side-effects of chemotherapy.

Fiona Powrie appointed new Deputy Chair of Wellcome’s Board of Governors

Fiona Powrie, Director of the Kennedy Institute of Rheumatology at the University of Oxford has been selected as the next Deputy Chair of Wellcome’s Board of Governors.

World’s first cancer prevention trial to test diabetes drug in patients with high-risk genetic condition

Oxford researchers will lead a £2m national cancer prevention trial to assess the benefit a diabetes drug has in patients with Li Fraumeni Syndrome (LFS), a genetic condition that impacts 1 in 20,000 people worldwide and puts them at a 70-90% lifetime risk of cancer.

One high altitude explorer acknowledges another

NASA Astronaut and Physiologist Dr Jessica Meir unveils The Physiological Society blue plaque in honour of fellow pioneering Physiologist and Scientific Explorer Mabel FitzGerald.

Oxford-led research maps milestone stage of human development for the first time

Scientists have shed light on an important stage of early embryonic development that has never been fully mapped out in humans before.